The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020.
The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020.
复制标题
DOI：
10.1038/s41416-020-01182-z
复制
发表时间：
2021-03
影响因子：
8.8
通讯作者：
Horgan K
中科院分区：
文献类型：
--
作者：
Gathani T;Clayton G;MacInnes E;Horgan K
COVID-19大流行导致的癌症诊断和治疗延迟是一个广泛关注的问题，但不同肿瘤部位的挑战规模尚不清楚。分析了英国NHS收集的英格兰癌症等待时间数据，以比较2020年前6个月与2019年同期的乳腺癌活动。疑似乳腺癌的转诊数量减少了28%（N = 231，765 vs N = 322，994），首次接受乳腺癌诊断治疗的患者数量减少了16%（N = 19，965 vs N = 23，881）。这些数据表明，2020年上半年诊断出的乳腺癌数量并不像最初担心的那样低，而2020年3月暂停常规筛查可以解释很大一部分短缺。需要进一步开展工作，以详细研究管理COVID-19大流行的措施对乳腺癌结果的影响。
Delays in cancer diagnosis and treatment due to the COVID-19 pandemic is a widespread source of concern, but the scale of the challenge for different tumour sites is not known. Routinely collected NHS England Cancer Waiting Time data were analysed to compare activity for breast cancer in the first 6 months of 2020 compared to the same time period in 2019. The number of referrals for suspected breast cancer was 28% lower (N = 231,765 versus N = 322,994), and the number of patients who received their first treatment for a breast cancer diagnosis was 16% lower (N = 19,965 versus N = 23,881). These data suggest that the number of breast cancers diagnosed during the first half of 2020 is not as low as initially feared, and a substantial proportion of the shortfall can be explained by the suspension of routine screening in March 2020. Further work is needed to examine in detail the impact of measures to manage the COVID-19 pandemic on breast cancer outcomes.
DOI：
10.1016/s1470-2045(20)30391-0
发表时间：
2020-08
期刊：
The Lancet. Oncology
影响因子：
--
作者：
Hamilton W
通讯作者：
Hamilton W
影响因子：
51.1
作者：
Sud, Amit;Torr, Bethany;Turnbull, Clare
通讯作者：
Turnbull, Clare
影响因子：
51.1
作者：
Maringe, Camille;Spicer, James;Aggarwal, Ajay
通讯作者：
Aggarwal, Ajay